Search results
Eating More of This Fruit May Improve Memory and Alzheimer’s Symptoms, Study Finds
Prevention· 5 days agoA substance found in pomegranates, known as urolithin A, may improve memory and Alzheimer’s disease...
EXCLUSIVE: Webuy Global Dives Into Longevity Market with NEONE, Aiming to Revitalize Health...
Benzinga via Yahoo Finance· 18 hours agoWebuy Global Ltd (NASDAQ:WBUY) announced its entry into the nutraceutical and longevity markets with...
ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
Zacks via Yahoo Finance· 4 days agoChromaDex (CDXC) rises 12% as the FDA grants the Orphan Drug Designation and the Rare Pediatric...
ChromaDex (NASDAQ:CDXC) Given Buy Rating at Roth Mkm
ETF DAILY NEWS· 1 day agoRoth Mkm restated their buy rating on shares of ChromaDex (NASDAQ:CDXC – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $6.00 target price on ...
ChromaDex secures FDA orphan drug status for AT treatment By Investing.com
Investing.com· 7 days agoFood & Drug Administration (FDA) for its investigational product NRC, aimed at treating Ataxia...
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day...
Benzinga· 7 days agoShares of GameStop Corp. GME fell sharply during Friday's session after the company released...
Understanding Optimal Protein Intake
Mercola· 2 days agoDietary protein is essential for building and repairing tissues, including muscles and organs. While there are hundreds of amino acids in nature, humans only use about 20 of them to make the ...
CELFULL Introduces Celfavor(R) Microparticle Technology, Transforming Conventional Drug Delivery...
Digital Journal· 2 days agoBased on in-depth research into the mechanisms of aging, CELFULL has identified numerous valuable anti-aging ingredients. However, these ingredients are often highly reactive, presenting significant ...
ChromaDex's NRC Gets FDA Orphan, Rare Pediatric Disease Designation; Stock Up
RTT News· 7 days agoChromaDex Corp. (CDXC) announced on Friday that the company's Nicotinamide Riboside Chloride or NRC has received the U.S. Food & Drug Administration's Orphan Drug Designation ...
